NCT07109570

Brief Summary

The goal of this observational study is to measure effort using esophageal pressure measurements, oxygen consumption and diaphragm activity in mechanically ventilated Intensive Care Unit patients during a Spontaneous Breathing Trial. The main question aims to answer whether the sEMG signal derived from the SERA device, effort parameters and oxygen consumption have an association with weaning failure. Participants will be measured while performing a spontaneous breathing trial.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
37mo left

Started Jul 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Jul 2025Jun 2029

Study Start

First participant enrolled

July 8, 2025

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

July 31, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 7, 2025

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2029

Last Updated

November 26, 2025

Status Verified

November 1, 2025

Enrollment Period

3.5 years

First QC Date

July 31, 2025

Last Update Submit

November 20, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Extubation failure

    Extubation failure is defined by the need for reintubation or death.

    48 hours after extubation

  • sEMG differences during SBT

    The AUC of the voltage signal, the phasic level (difference between tonic level and maximum level) and the tonic level (base level).

    10 minutes before switch from support to no support ventilation, the whole duration of the SBT, and the 10 minutes after the SBT when there is again support.

Secondary Outcomes (5)

  • Differences of oxygen consumption during SBT

    10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT

  • Differences of esophageal pressure swings measured with an esophageal catheter during SBT

    10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT

  • Differences of work of breathing measured with an esophageal catheter during SBT

    10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT

  • Differences of pressure-time product measured with an esophageal catheter during SBT

    10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT

  • Differences of rapid shallow breathing index during SBT

    10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The intended population consists of adults who are mechanically ventilated in the ICU and meet the criteria for a regular spontaneous breathing trial according to the ruling LUMC protocol.

You may qualify if:

  • years of age or older
  • Esophageal catheter in situ (standard of care)
  • Eligible for an SBT in the near future according to the LUMC SBT protocol currently valid

You may not qualify if:

  • Severe cardiac failure NYHA class IV without mechanical support (LVAD or Impella)
  • COPD Gold IV
  • Pregnancy
  • Patients with ECMO

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Leiden University Medical Centre

Leiden, 2300 ZA, Netherlands

RECRUITING

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Abraham Schoe, MD, PhD

CONTACT

Florence E Smits, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

July 31, 2025

First Posted

August 7, 2025

Study Start

July 8, 2025

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

June 1, 2029

Last Updated

November 26, 2025

Record last verified: 2025-11

Locations